We are live on
!
Find out more
RGLS
Regulus Therapeutics
RGLS
RGLS
Delisted
RGLS was delisted on the 24th of June, 2025.
24 hedge funds and large institutions have $13.8M invested in Regulus Therapeutics in 2022 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 5 increasing their positions, 4 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
25% more repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 4
14.01% more ownership
Funds ownership: 41.57% → 55.58% (+14%)
10% more capital invested
Capital invested by funds: $12.6M → $13.8M (+$1.24M)
11% less funds holding
Funds holding: 27 → 24 (-3)
43% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 7
Holders
24
Holders Change
-3
Holders Change %
-11.11%
% of All Funds
0.41%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
5
Reduced
4
Closed
7
Calls
$1.14M
Puts
–
Net Calls
+$1.14M
Net Calls Change
-$144K
Top Buyers
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$3.95M |
| 2 |
Dimensional Fund Advisors
Austin,
Texas
|
+$56.9K |
| 3 |
BlackRock
New York
|
+$42.7K |
| 4 |
HF
HRT Financial
New York
|
+$40.9K |
| 5 |
Commonwealth Equity Services
Waltham,
Massachusetts
|
+$20.7K |
Top Sellers
| 1 |
IC
Ikarian Capital
Dallas,
Texas
|
-$217K |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
-$162K |
| 3 |
Citadel Advisors
Miami,
Florida
|
-$42.6K |
| 4 |
BFM
Boothbay Fund Management
New York
|
-$24K |
| 5 |
VF
Virtu Financial
New York
|
-$21K |
